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1980.-A sleep-promoting factor was extracted from human urine. Intraventricular infusion of the purified material induced excess slow-wave sleep in rats and rabbits for 5-10 h after the infusion. Chemical properties of the urinary factor were similar to those of factor S derived from whole brains of sleep-deprived goats, sheep, and rabbits. The behavior of the urinary factor in two ion exchange chromatographic steps, high voltage electrophoresis, gel-filtration, and ultrafiltration was similar to that of factor S. Effects of the purified urinary factor on slow-wave sleep of rats and rabbits were similar in time-course and duration to those of factor S from brain. However, the factor obtained from human urine did not increase the amplitude of cortical slow waves to the same extent as did factor S from brains of sleep-deprived animals.
slow-wave sleep; neurohumoral regulation of sleep; rabbits; rats AN ENDOGENOUS sleep-promoting substance, factor S, has been purified from cerebrospinal fluid (CSF) of goats (29) and from brains of sleep-deprived sheep, goats, and rabbits (5, 8) . Factor S induces excess slow-wave sleep (SWS) for several hours following infusion into cerebral ventricles of rats (2, 8, 9) and rabbits (5, 8) . The excess SWS is similar to that which follows sleep-deprivation; both are characterized by delta waves that exceed, in amplitude, the maximum values recorded in the same animal during normal sleep (5, 8) . In rats and rabbits the excess SWS exhibits a normal episodic pattern (5) . Factor S appears to be a low molecular weight peptide; the effective dose is less than 150 pmol per rabbit (5).
The early work by Legendre and Pieron (6) and Schnedorf and Ivy (13) indicated that sleep-promoting activity was present in CSF of sleep-deprived dogs. The initial work on factor S (2, 9) extended these observations to CSF derived from goats. However, it was not feasible to collect CSF in amounts needed for systematic studies of the chemistry and physiology of factor S. Therefore, other potential sources of factor S were investigated, including brain tissue from sleep-deprived goats, sheep, and rabbits, and from slaughterhouse cattle (5, 8) . Since factor S appears to be stable, both in vivo and in vitro, we thought it possible that factor S or some derivative of factor S might be absorbed into the blood with the normal reabsorption of CSF, and eventually be concentrated and excreted by the kidneys. If this were the case, urine might provide a readily available and inexpensive source of starting material for future studies of factor S.
We shall describe the parallel purifications of a sleeppromoting material from human urine (SPU) and of factor S from brain. The effects of SPU and factor S on rat and rabbit SWS are described. These effects are compared to results from our bioassays of other sleepinducing agents, i.e., arginine-vasotocin (10) and deltasleep-inducing peptide (15).
MATERIALS
Human urine from first morning micturition was obtained from healthy male adults, age 23-33 yr, and frozen within I h of collection. Samples from several donors were pooled into 0.5-to 2-l lots prior to starting the purification procedure. Whole brains from rabbits were purchased from Pel-Freez Biologicals. After the animals were killed, their brains were excised rapidly, frozen in liquid nitrogen, and stored in dry ice until the extraction procedure was started.
All chemicals were of reagent grade. Delta-sleep-inducing peptide was purchased from Vega Biochemicals. Arginine-vasotocin was a gift from Merck Sharp & Dohme. Sterile nonpyrogenic water and saline were purchased from Travenol Laboratories.
METHODS

Extraction
of sleep-promoting materials. Rabbit brains were extracted with acid-acetone using the method of Chang and Leeman (1) as previously described (5) . The subsequent extraction with petroleum ether removed most lipids and acetone from the aqueous phase. Residual acetone and petroleum ether were removed by low-pressure evaporation at 37" C. The resulting aqueous brain extract was treated in the same manner as urine samples. Sleep-promoting material was partially purified from both sources as outlined in Fig. 1 . In preparation for ion exchange chromatography, urine and brain extracts were titrated to pH 7.0 with NHdOH. Precipitates from urine or particulate matter in brain extracts were removed by centrifugation at 14,000 g for 1 h at 4OC. The conductivity of the supernate was determined and, when necessary, water was added until the conductivity was equivalent to 130-150 mM NaCl. In some instances samples were stored overnight at 4°C; and additional precipitate formed during cold storage was removed by filtration through Whatman 31 paper. First ion exchange step. The first step of purification involved cation exchange chromatography on CM-Sephadex C-25. The ion exchanger was swollen in distilled water, and then washed with 0.5 N HCl. Excess HCl was removed by rinsing with distilled water. Next the resin was washed with a solution containing an excess of NHJ+ until the pH of the slurry was close to 7.0. At this point the resin was equilibrated with 50 mM NHd-acetate buffer, pH 7.0, and was stored at 4OC until used. The extracts were applied at room temperature to CM-Sephadex columns having bed volumes of 100 ml/liter of original urine or 1.5 kg of brain. The columns were developed by washing with three bed volumes of pH 7.0, 50 mM NHd-acetate buffer, followed by five bed volumes of pH 9.0,50 mM NHd-acetate buffer. The sleep-promoting material remained bound to the resin, and these pH 7 and 9 eluates were discarded. Sleep-promoting material was eluted from the columns with six bed volumes of 1 M NaCl followed by eight bed volumes of 1 M acetic acid. These eluates were pooled and the volume was reduced to 20% of the original by low pressure evaporation at 37°C.
Gel-filtration. The concentrated NaCl-acetic acid eluates from the cation exchange step were fractionated by two successive gel-filtrations on G-10 Sephadex. G-10 Sephadex columns were equilibrated and developed in 50 mM acetic acid at 4°C and were calibrated as previously described (8) with blue dextran 2000 (to determine the void volume, V& [ 14C]sucrose, and NaCl. The concentrates were applied to the G-10 Sephadex in volumes not exceeding 5% of the column bed volume. The fraction saved from the first filtration was from Vo to the beginning of the NaCl marker. This fraction was lyophilized, then dissolved in an appropriate volume of 50 mM acetic acid for reapplication to G-10 Sephadex as above. The fraction saved from the second gel-filtration was from Vo to the peak of the [ 14C]sucrose marker (V,,,). This eluate was lyophilized in preparation for the next stage of purification. At this stage aliquots also were reserved for biological assay.
Second ion exchange step. It was found previously (5) that the charge on factor S is altered subsequent to its elution with acetic acid and NaCl from the first cation exchange column. This loss of net positive charge permits further purification by reapplication of the product of steps A-C ( Fig. 1 ) to another cation exchange column. CM-Sephadex C-25 was prepared as described above. In each individual preparation the same amount of resin was used in the first and second ion exchange steps. The lyophilized eluates from gel-filtration were dissolved in one-half bed volume of pH 7.0, 50 mM NH4-acetate buffer and applied to the column. Next, three bed volumes of this buffer were eluted through the CM-Sephadex. The column was then eluted with six bed volumes of 1 M NaCl followed by eight bed volumes of 1 M acetic acid. The sleep-promoting material no longer binds to the CM-Sephadex and is recovered in the pH 7.0 eluate. This eluate was lyophilized, and the product dissolved in an appropriate volume of 50 mM acetic acid for gelfiltration on Sephadex G-10. The fraction Vo to V,,, was lyophilized and saved for bioassay, or in some cases, for high-voltage paper electrophoresis. To determine whether any sleep-promoting activity remained bound to the resin after the pH 7.0 elution, the NaCl-acetic acid eluates were prepared for biological assay as described in First ion exchange step and Gel-filtration.
Electrophoresis.
Human urine extracts, purified by two ion exchange steps and gel-filtration, were purified further by high-voltage electrophoresis on Whatman 3 paper. The pH 7.0 eluate from the second ion exchange step was applied as a 3-cm band in amounts corresponding to 2.5 1 of donor urine. Methionine was spotted to either side of the urine sample as a marker. The electrophoresis was carried out at pH 1.9,65 Vcm-', l-8°C for 70 min in formic acid/acetic acid/water, 150:100:750 (vol/ vol) using a Savant model HVE-8036 apparatus. After development the paper was air dried overnight, and the strips of paper containing the methionine marker were stained with ninhydrin. Under these conditions methionine migrated about 18 cm. Sleep-promoting material was found to migrate 0.22 to 0.44 times this distance. This section and several sections to either side of it were eluted with water. The eluates were subjected to a final gel-filtration on Sephadex G-10. The fractions from Vo to V,,, were saved for bioassay.
Fhorescamine reaction. The product from human urine or rabbit brain after the first ion exchange and two gel-filtration steps was reacted with fluorescamine (Fluram; Hoffmann-La Roche). The samples, which represented 50 g of rabbit brain or 300 ml of urine, were taken up in 1.5 ml of 0.1 M borate-phosphate buffer, pH 8.0. Three successive additions of 0.5 ml of Fluram (0.3 mg/ml acetone) were added to the solution at 2-min intervals. Acetone was then removed by evaporation under reduced pressure, and the aqueous residue was applied to a 150-ml bed volume G-10 Sephadex column. The fraction Vo to V,,, was saved for bioassay. Aromatic substitution of amino acids increases their retention on dextran gels (11). Fluorescamine and its amine derivatives contain aromatic rings; therefore, gel-filtration through Sephadex G-10 permits the separation of compounds that react with Fluram from those that do not. soldered to these screws. A ventricular guide tube was also implanted 4 mm lateral and 1 mm posterior to the bregma using the same techniques as previously described for rats (3) . Dental cement was used to insulate the leads and to secure the guide tube and EEG plug to the skull. At the completion of the operation each animal received 150,000 u,nits of Bicillin (Wyeth) and a topical application of Neomyocin (McKesson) around the incision. At least 1 wk was allowed for recovery. Rabbits were brought to the experimental cages for an overnight acclimation period before each experiment.
UMO5 ultrafiltration.
An aliquot of the product obtained from human urine after the first ion exchange and gel-filtration steps was subjected to ultrafiltration through Diaflo UM05 membranes (Amicon). The lyophilized sample was taken up in an appropriate volume of sterile nonpyrogenic water; tracer quantities of [ 14C]sucrose were added for calibration of the filters as previously described (2). Ultrafiltration was carried out at 50 lb/in2 under nitrogen. The filtrand was repeatedly washed with water until 80% of the sucrose was recovered in the filtrate. The filtrate was lyophilized and stored at -20°C until it was assayed for sleep-promoting activity.
Prior to biological assay all samples were subjected to a gel-filtration on a 150-ml bed volume G-10 Sephadex column equilibrated and developed with 50 mM acetic acid in sterile nonpyrogenic water. The fraction from Vo to V,,, was lyophilized and stored at -20°C until assayed. Experimental samples were dissolved in an appropriate volume of artificial CSF (in mM): 3 KCl, 1.15 CaCl2, and 0.96 MgC12 in nonpyrogenic sterile saline (155 mM NaCl). Samples were infused intraventricularly over a 90-min period at a rate of 3 $/min. Pressure at the tip of the probe was monitored to ensure that material was infused into the ventricle (3). EEG was recorded during the infusion and for the next 6 h. Six-hour control recordings were obtained from uninfused rabbits; these data provided each rabbit with individual control values. Duration and patterns of SWS from rabbits following control infusions of artificial CSF do not differ from those of uninfused rabbits (8).
Reagent blanks. With each step of purification, "reagent blanks" were prepared for control bioassays to ensure that contaminants, which included contributions from reagents, columns, etc., did not produce a sleeppromoting effect. CM-Sephadex C-25 columns were prepared and eluted in the same way as those columns that received biological samples, substituting pH 7.0, 50 mM NH4-acetate buffer for sample. These "blank" eluates were then evaporated under reduced pressure, lyophilized, and subjected to gel-filtration as were biological samples before assay. For fluorescamine controls, a G-10 Sephadex column was developed without application of any sample. The resulting eluate was lyophilized and reacted with Fluram..This sample was evaporated under reduced pressure, then applied to a 150 ml G-10 Sephadex column. The fraction Vo to V,,, was saved for bioassay. In all cases the amount of "reagent blank" infused in terms of volume of CM-Sephadex eluate and/or G-10 Sephadex eluate was the equivalent of that used when biological samples were prepared. None of these "blank preparations" had a sleep-promoting effect. The lack of effect on rat and rabbit SWS of UM05 ultrafiltration "blank preparations" was previously reported (8).
EEG was recorded on a Grass model 5P5 polygraph. EEG leads were connected to the polygraph via a rotary commutator (BRS/LVE, Tech Serv), which allowed unrestrained movement of the rabbits. The EEG signal was led through an electrical filter (Buxco Electronics) and the 0.5-to ~-HZ component was rectified. The filtered rectified signal was recorded on the polygraph simultaneously with the EEG. The slow wave rectified signal was also electrically integrated, and integrals were printed on tape every 2 min. The EEG amplifiers, filters, and integrators were calibrated each day with a sine wave of 480 RMS ,uV and a frequency of 1.7 Hz. Bodily movements were recorded from a water-filled tube attached to the EEG cable and connected to a pressure transducer.
Rabbit bioassay. Male New Zealand White rabbits, weighing 3-4 kg, were obtained from a local supplier. After being deprived of food and water for 24 h, rabbits were anesthetized with Nembutal (Abbott) (15-30 mg/ kg body wt). Stainless steel screws were implanted over the frontal, parietal, and occipital cortex. Short EEG leads from a nlugl (ITT-Cannon #MIKO-1-7SH) were
Two methods were used to analyze the EEG. 1) Duration of SWS was determined by visual scoring of the EEG. The duration of SWS episodes was defined as that period of time during which EEG slow waves (0.5-4 Hz) were not interrupted for more than 10 s. If the highfrequency low-voltage EEG characteristic of waking animals continued for more than 10 s, the next delta waves were counted as a new SWS episode. The substantial differences between amplitude of slow waves, of a sleeping vs. a waking animal (8) are readily distinguishable on the filtered rectified EEG recording. For this reason, visual assessment of this record was also used in determining SWS values. 2) Delta wave activity was calculated from the digital print-out of slow wave integrals. This activity is a combined measure of both amplitude and duration of delta waves. Percent delta wave activity was computed from the following expression: % delta = A v . r 100 (I3 -i EA)/(Es -EA), in which E is the mean slow Rabbits were housed in a room with a 12-h light-dark cycle. Rabbits sleep episodically throughout light and dark periods. Most SWS episodes last less than 1 min, although it is not uncommon to observe episodes of 5-10 min (Fig. 4) . During daylight hours SWS episodes typically occupy from 35 to 45% of each hour (Fig. 2) . Slightly less time is spent in SWS during dark hours. Experiments were conducted between 0900 and 1700 h (daylight).
Rat bioassay. Male Sprague-Dawley rats, weighing 175 to 275 g, were obtained from Charles River. Rats were provided with ventricular guide tubes and EEG screw electrodes as previously described* (3). Rats were allowed to recover from the operation for 1 wk. EEG, filtered (0.5-4 Hz) rectified EEG, and rat movements were recorded as described for rabbits. Duration of SWS was determined by visual scoring of these records. Rats were allowed to acclimate to the experimental cage for 1 wk. Experimental samples were dissolved in an appropriate volume of artificial CSF and infused over a 30-min period at a rate of 3 @/min. EEG was recorded during the infusion and for the next 18 h. For each rat, control values of duration of SWS were obtained after infusion of solutions of artificial CSF either the day before or the day after infusion of experimental samples. In some cases control values were obtained both the day before and after infusion of experimental material; no substantial differences between these control values were observed.
Rats were housed in a room with a 10-h light-14-h dark cycle. Rats sleep episodically. SWS episodes occupy substantially more time during daylight than during dark hours (8). Infusions were done at the end of the light period, and lights were turned off immediately following the infusion.
Units. Because the bioassays were insufficiently quantitative to establish a unit of biological activity, concentrations and doses are expressed in terms of ml urine I  I  I  I1  I1  I1  I  II  I  I  I  I  I  Il l equivalents (mlu) of the original starting material or in terms of gram brain equivalents (gbe) of the original starting material.
RESULTS
Physiological
properties of SPU and factor S. The effects on rabbit SWS of materials purified through the first cation exchange and gel-filtration steps are illustrated in Fig. 3 . An increase in duration of SWS was observed following infusion of extracts from rabbit brain and human urine. It is probable that the doses employed resulted in maximum responses.
In the course of hundreds of assays of factor S or SPU, the duration of SWS never exceeded 85% in any 1 h. Animals under the influence of factor S and SPU wake up periodically to eat, drink, groom, etc.
The time courses of the responses to SPU and factor S were similar. There was no increase in SWS above control values during the 1st h after the infusion. The excess SWS was clearly evident in the 2nd h and peaked during the 3rd-5th postinfusion hour. When responses were monitored beyond the routine 6-h recording period, excess SWS was observed up to 10 h after infusion of either factor S from brain or SPU. The excess SWS appeared to be normal; the animals were easily aroused by noise, and their sleep remained episodic. SPU increases rabbit SWS duration by increasing the number of sleep episodes that last longer than 2 min (Fig. 4) , as does factor S (5).
The effects of SPU on rat SWS are shown in Table 1 . The duration of SWS following infusion of material purified from urine was significantly greater than the duration of SWS which followed infusion of control solutions of artificial CSF. The effect was observed in rats during the first postinfusion hour. Excess SWS was greatest during postinfusion hours 1-6; however, SWS above The mean values are an average from 9 assays on 5 rats. SWS, slowwave sleep. Each rat received a dose of urine extract equivalent to 20-50 ml of original urine (mlu). The urine extract was purified .by ion exchange and gel-filtration chromatography.
control values continued during hours 6-12 following the infusion. A similar effect on rat SWS was observed following infusion of factor S (8). During postinfusion hours 12-18, there were no significant differences in duration of SWS following experimental or control infusions. A comparison of the patterns of SWS after infusion of SPU to control SWS patterns shows their similar episodic nature (Fig. 4) . The increased duration of SWS following SPU infusion resulted from an increased total number of sleep episodes. Factor S must reach the aqueduct of Sylvius to be effective (8). This was also observed with urine sleeppromoting material. Two rats and one rabbit that failed to exhibit increased SWS in response to SPU infusions were infused with methylene blue prior to death to determine the position of the ventricular probe (3). In these animals the dye was found in the subarachnoid space, indicating that the ventricular probe had not been properly placed. Factor S from rabbit brain consistently caused an increase in amplitude of rabbit EEG slow waves, thereby increasing % delta activity values above % SWS values (Table 2 ). In contrast, the effect of SPU on amplitude of EEG slow waves was variable; only 6 of the 15 rabbits infused with SPU showed a clear increase in amplitude of slow waves during sleep. Consequently, the % delta activity value was not significantly above the % SWS value (Table 2) . After infusion of urine extracts subjected to further purification, the effect on amplitude was still inconsistent; 9 of 18 rabbits showed a substantial increase in slow-wave amplitude.
Chemical properties of SPU and factor S. Table 2 . Each rabbit acted as its own control. N is the total number of assays. The bracketed number is the number of individual rabbits used for these assays.
factor S and SPU appear to have different effects on amplitude of EEG slow waves, their common behavior in several purification steps indicates their chemical similarity. SPU and factor S both undergo a loss of net positive charge following the first ion exchange step of Fig. 1 . When extracts purified through the first cation exchange and gel-filtration steps were reapplied to CMSephadex, most of the sleep-promoting material failed to bind to the resin and consequently eluted with the pH 7.0 starting buffer (Table 3) . Most other positively charged substances in these extracts do not undergo a change in binding characteristics; therefore, these substances still bind to the CM-Sephadex.
Thus the second cation exchange step provides a simple preparative procedure for further purifi'cation of the sleep-promoting materials. 7% SWS values are means t SE, measured 2-6 h after infusion. For abbreviations, see Table 2 . Each rabbit acted as its own control. N is the total number of assays. The bracketed number is the number of individual rabbits used for these assays.
sleep-promoting substance reacted with fluorescamine. Thus exposure to Fluram failed to alter the mobilities of factor S or SPU during gel-filtration through Sephadex G-10 columns (Table 4 ). The failure of both sleep-promoting substances to react with Fluram indicated that these substances may not contain primary or secondary amino groups after the charge change. This technique of reacting contaminating materials with Fluram, followed by gel-filtration, also provides a simple rapid method for their separation from the sleep-promo.ting materials.
A comparison of the mobility of these sleep-promoting substances during high voltage paper electrophoresis also indicates chemical similarities.
The boundaries of the sections of paper from which SPU and brain factor S were eluted after electrophoresis overlapped. SPU migrated to a section corresponding to 0.22-0.44 times the migration distance of the methionine marker (Table 4) . Factor S migrated to a section with boundaries relative to methionine of 0.40 to 0.55, which corresponds to Rlys values of 0.2 to 0.27 as previously reported (5). The slightly higher mobility obtained for factor S may* be attributed to the fact that our earlier electrophoreses of the brain factor were carried out at a higher temperature than used for the present studies of the material from urine. Factor S migrated much further in the direction of the negative pole when it was partially purified only by gel-filtration on G-10 Sephadex and ultrafiltration through Diaflo UMlO and UM05 membranes (4) . The lower electrophoretic mobility of these substances after the cation exchange chromatographic step provides additional evidence for a net loss of positive charge. Nevertheless, the biological activity of factor S after the charge change was indistinguishable from factor S purified by molecular sieving techniques only.
Comparison
of SPU and factor S with two other reported sleep-inducing substances.
The characteristic time course of the excess SWS induced by SPU or factor S (Fig. 3) distinguishes these substances from other endogenous materials reported to induce natural sleep. Table 5 . Infusion of 25 pmol of arg-vasotocin produced a transient increase of SWS within th.e 1st h followed by return to control values. During the brief period of excess SWS, sleep patterns remained episodic, and animals could be aroused by our entry into the experimental room. Arg-vasotocin also caused a marked increase in amplitude of EEG slow waves; the time course of this effect paralleled the effect on duration of SWS.
Schoenenberger and colleagues (14,15) have described the isolation, physiological properties, and chemical structure of delta-sleep-inducing peptide. In our bioassay system it had no effect on rabbit SWS (Table 5 ).
DISCUSSION
Factor S obtained from CSF or from brain is known to Chemical similarities between factor S and SPU are pass through Amicon UM05 membranes that retain molecules of molecular weight greater than 500 (8). SPU also exhibited by their parallel behavior in numerous preparpassed through UM05 filters as shown in Table 4 . Neither ative procedures. The electrophoretic mobility of factor S purified only by molecular sieving techniques is close to that of lysine (4) ; this provides evidence of a strong positive charge on factor S in its native form. Indeed, it was these preliminary results (4) that led to the use of cation exchange chromatography as an initial preparative step. Initially both sleep-promoting substances bind to the cation exchanger at relatively high ionic strength and do not elute from the column with the pH 9.0 buffer. These results supported the deduction that the native materials are strongly positively charged. However, both substances appear to lose net positive charge during the ion exchange step; they fail to bind on reapplication to the cation exchanger. Furthermore, after the first ion exchange step, the electrophoretic mobility of factor S at pH 1.9 is greatly reduced. The low electrophoretic mobility of SPU after the first ion exchange step is also consistent with a charge change. It is possible that amino groups on native factor S are acetylated during the lowpressure evaporation at 37°C in concentrated NaCl and acetic acid (following the first ion exchange step, Fig. 1 ).
Alternatively, a lactone or ester linkage may be hydrolyzed during this process. Although the exact nature of the charge change is unknown, its occurrence in both substances provides strong evidence of their chemical similarity.
Their similar behavior in other preparative steps provides additional evidence of their common properties. Both sleep-promoting materials pass through Amicon UM05 filters and are found in the same gel-filtration fraction. These data indicate a probable molecular weight between 250 and 500 daltons. After the first cation exchange step neither sleep-promoting substance appears to contain either a primary or secondary amino group readily accessible for reaction with fluorescamine.
The sleep-promoting factors from brain and from urine also elicit similar physiological responses. Both have prolonged effects on SWS duration in two species with markedly different 24-h sleep patterns. The time courses of increased SWS elicited by these substances were parallel (Fig. 3) and quite different from the transient action of arg-vasotocin.
Furthermore, in rabbits their effects on episodic patterns of SWS were similar. In both rats and rabbits these sleep-promoting substances must reach the aqueduct of Sylvius to be effective. The only indication KRUEGER, BACSIK, AND GARCIA-ARRARAS that SPU might differ from factor S is the inconsistent effect of SPU on amplitude of rabbit EEG slow waves. It is possible that material in urine may be a metabolite of factor S, or that human factor S may be slightly different from rabbit factor S. Alternatively, two separate substances may be independently responsible for the effects on duration of SWS and on amplitude of EEG slow waves, or impurities may be present in urine samples that block the effect on amplitude of EEG slow waves.
Male urine from first morning micturition was used routinely for the following reasons. 1) Diurnal variation in factor S concentrations in brain and CSF is possible (12); urine output varies throughout the day. To minimize probable sample inconsistencies we used urine collected at roughly the same time of day following the common behavioral state of sleep. 2) Factor S may be at highest concentrations in brain at the onset of sleep and present in urine on awakening. 3) Male urine was used because it is uncomplicated by menstrual cycles. Although first AM urine was routinely used, preliminary results indicate the presence of sleep-promoting material in urine collected at 2:00 and at 1O:OO PM.
The effects of arginine-vasotocin on rabbit SWS that we observed were similar to the effects on cat SWS that during the brief period of excess SWS induced by arg-vasotocin, an increase in the amplitude of EEG slow waves was observed that was similar to the increases observed following sleep-deprivation and factor S infusion (8).
Differences between factor S and delta-sleep-inducing peptide have been discussed previously (5, 8) . The lack of effect of the delta-sleep-inducing peptide on rabbit SWS in our bioassay reinforces the distinctions between these peptides. We infused the reported effective intraventricular dose of delta-sleep-inducing peptide (6 nmol/ kg body wt) (7) over a longer period of time than that routinely used by Monnier's group (7, 14, 15). Perhaps this can account for delta-sleep-inducing peptide inactivity in our bioassay; however, with factor S and urine sleep-promoting material the infusion rate does not seem to be critical. Infusion of these materials at three times the rate routinely used (see METHODS) yielded similar positive results. 
